Patents by Inventor Luiz Belardinelli

Luiz Belardinelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220226301
    Abstract: Disclosed herein are methods and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using potassium channel inhibitors and class I antiarrhythmic agents. Also disclosed herein are methods and kits for treating a heart condition via an intravenously, orally, or inhalationally administered fixed-dose combination of a sodium channel blocker and a class I antiarrhythmic agent.
    Type: Application
    Filed: March 30, 2022
    Publication date: July 21, 2022
    Inventors: Luiz BELARDINELLI, Carlos SCHULER, Miguel GUZMAN
  • Publication number: 20220218686
    Abstract: Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also disclosed.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 14, 2022
    Inventors: Michael Laird Hurrey, Luiz Belardinelli, Prashanti Madhavapeddi, Carlos Schuler
  • Publication number: 20210228825
    Abstract: Disclosed herein is a method for evaluating Brugada syndrome (BrS) in a subject in need thereof. In some embodiments, the method comprises administering an aerosol of a sodium channel blocker to the subject. Also disclosed herein are compositions, unit doses, and kits for evaluating Brugada syndrome in a subject in need thereof.
    Type: Application
    Filed: June 5, 2019
    Publication date: July 29, 2021
    Inventors: Rangachari NARASIMHAN, Luiz BELARDINELLI, Carlos A. SCHULER
  • Patent number: 11020384
    Abstract: Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also disclosed.
    Type: Grant
    Filed: June 15, 2020
    Date of Patent: June 1, 2021
    Assignee: InCarda Therapeutics, Inc.
    Inventors: Michael Laird Hurrey, Luiz Belardinelli, Prashanti Madhavapeddi, Carlos Schuler
  • Patent number: 11007185
    Abstract: Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also disclosed.
    Type: Grant
    Filed: June 15, 2020
    Date of Patent: May 18, 2021
    Assignee: InCarda Therapeutics, Inc.
    Inventors: Michael Laird Hurrey, Luiz Belardinelli, Prashanti Madhavapeddi, Carlos Schuler
  • Publication number: 20210030732
    Abstract: Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also disclosed.
    Type: Application
    Filed: June 15, 2020
    Publication date: February 4, 2021
    Inventors: Michael Laird HURREY, Luiz BELARDINELLI, Prashanti MADHAVAPEDDI, Carlos SCHULER
  • Publication number: 20210030670
    Abstract: Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also disclosed.
    Type: Application
    Filed: June 15, 2020
    Publication date: February 4, 2021
    Inventors: Michael Laird HURREY, Luiz BELARDINELLI, Prashanti MADHAVAPEDDI, Carlos SCHULER
  • Patent number: 10744087
    Abstract: Disclosed herein are methods, formulations, and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using selective ?1 adrenergic receptor blockers. Also disclosed herein are methods, formulations, and kits for treating a heart condition via inhalation or intranasal spray administration of selective ?1 adrenergic receptor blocker and class I antiarrhythmic agent.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: August 18, 2020
    Assignee: InCarda Therapeutics, Inc.
    Inventors: Luiz Belardinelli, Rangachari Narasimhan, Carlos Schuler
  • Publication number: 20200179278
    Abstract: Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also contemplated.
    Type: Application
    Filed: February 12, 2020
    Publication date: June 11, 2020
    Inventors: Carlos SCHULER, Rangachari NARASIMHAN, Luiz BELARDINELLI, Prashanti MADHAVAPEDDI
  • Publication number: 20200179279
    Abstract: Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also contemplated.
    Type: Application
    Filed: February 12, 2020
    Publication date: June 11, 2020
    Inventors: Carlos SCHULER, Rangachari NARASIMHAN, Luiz BELARDINELLI, Prashanti MADHAVAPEDDI
  • Patent number: 10660578
    Abstract: Disclosed herein are methods of treating cardiac arrhythmia with electronic monitoring in a timely manner. Also disclosed herein are systems for electronic monitoring of cardiac arrhythmia.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: May 26, 2020
    Assignee: InCarda Therapeutics, Inc.
    Inventors: Rangachari Narasimhan, Luiz Belardinelli, Carlos A. Schuler
  • Patent number: 10441537
    Abstract: Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also contemplated.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: October 15, 2019
    Assignee: InCarda Therapeutics, Inc.
    Inventors: Carlos Schuler, Rangachari Narasimhan, Luiz Belardinelli, Prashanti Madhavapeddi
  • Publication number: 20190290581
    Abstract: Disclosed herein are methods, formulations, and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using selective ?1 adrenergic receptor blockers. Also disclosed herein are methods, formulations, and kits for treating a heart condition via inhalation or intranasal spray administration of selective ?1 adrenergic receptor blocker and class I antiarrhythmic agent.
    Type: Application
    Filed: March 22, 2019
    Publication date: September 26, 2019
    Inventors: Luiz BELARDINELLI, Rangachari NARASIMHAN, Carlos SCHULER
  • Publication number: 20190083396
    Abstract: Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also contemplated.
    Type: Application
    Filed: November 15, 2018
    Publication date: March 21, 2019
    Inventors: Carlos SCHULER, Rangachari NARASIMHAN, Luiz BELARDINELLI, Prashanti MADHAVAPEDDI
  • Publication number: 20180325818
    Abstract: Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also contemplated.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 15, 2018
    Inventors: Carlos SCHULER, Rangachari NARASIMHAN, Luiz BELARDINELLI, Prashanti MADHAVAPEDDI
  • Publication number: 20180303435
    Abstract: Disclosed herein are methods of treating cardiac arrhythmia with electronic monitoring in a timely manner. Also disclosed herein are systems for electronic monitoring of cardiac arrhythmia.
    Type: Application
    Filed: March 22, 2018
    Publication date: October 25, 2018
    Inventors: Rangachari NARASIMHAN, Luiz BELARDINELLI, Carlos A. SCHULER
  • Patent number: 10010294
    Abstract: Disclosed herein are methods of treating cardiac arrhythmia with electronic monitoring in a timely manner. Also disclosed herein are systems for electronic monitoring of cardiac arrhythmia.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: July 3, 2018
    Assignee: INCARDA THERAPEUTICS, INC.
    Inventors: Rangachari Narasimhan, Luiz Belardinelli, Carlos A. Schuler
  • Publication number: 20170238866
    Abstract: Disclosed herein are methods of treating cardiac arrhythmia with electronic monitoring in a timely manner. Also disclosed herein are systems for electronic monitoring of cardiac arrhythmia.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 24, 2017
    Inventors: Rangachari NARASIMHAN, Luiz BELARDINELLI, Carlos A. SCHULER
  • Patent number: 9549926
    Abstract: Provided are formulations comprising therapeutically effective amounts of ambrisentan or a pharmaceutically acceptable salt thereof and tadalafil or a pharmaceutically acceptable salt thereof and methods of treating and/or preventing pulmonary hypertension by administration of the formulations.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: January 24, 2017
    Assignee: Gilead Sciences, Inc.
    Inventors: Luiz Belardinelli, Hunter Campbell Gillies, Faquan Liang, John Shryock, Suya Yang
  • Patent number: RE47351
    Abstract: N-pyrazole substituted 2-adenosine compounds and methods for using the compounds as A2A-adenosine receptor agonists useful to stimulate mammalian coronary vasodilation for therapeutic purposes and as adjuncts in cardiological imaging.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: April 16, 2019
    Assignee: Gilead Sciences, Inc.
    Inventors: Jeff A. Zablocki, Elfatih O. Elzein, Venkata P. Palle, Luiz Belardinelli